What is the Multiple Sclerosis?

 



Multiple Sclerosis (MS) is an unpredictable, autoimmune disease that affects the central nervous system. In multiple sclerosis, the body’s own immune system produces cells and proteins (antibodies) that attack the fatty substance, myelin, which is responsible for protecting the nerve fibers. This is often characterized by relapsing episodes of neurologic impairment followed by remissions.

Multiple Sclerosis Epidemiology Segmentation in the 7MM

·         Prevalence of Multiple Sclerosis based on Gender

·         Total Prevalent Cases of Multiple Sclerosis

·         Phenotype-specific prevalent cases of Multiple Sclerosis

·         Prevalence of Multiple Sclerosis based on Age

·         Expanded Disability Status Scale

Multiple Sclerosis Epidemiological Insights Observed in the 7MM (2020)

·         The total prevalent cases of Multiple Sclerosis in the 7MM were found to be 1.2 million in the year 2020.

Multiple Sclerosis Market Insight           

The market size of Multiple Sclerosis in the 7MM was found to be almost USD 22,381 million in 2020.  

Multiple Sclerosis Market Drivers

·         Increasing population with Multiple Sclerosis

·         Extensively approved therapies

·         Wide range of R&D pipelines

·         Increasing awareness

Multiple Sclerosis Market Barriers

·         High cost of drugs

·         High incidence of adverse events

·         Patent expiration

Multiple Sclerosis Emerging Therapies

The emerging drugs in the Multiple Sclerosis market are

·         NeuroVax

·         CNM-Au8

·         Tolebrutinib

·         Evobrutinib/M2951

·         Ublituximab, and others

Multiple Sclerosis Market Companies 

The key players working in the Multiple Sclerosis market are

·         Immune Response BioPharma, Inc

·         Clene Nanomedicine

·         Sanofi

·         Merck Healthcare KGaA

·         TG Therapeutics, Inc., and several others

 

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.


Contact Us

Yash

info@delveinsight.com

Comments

Post a Comment

Popular posts from this blog

Emerging Trends in Thyroid Cancer Therapeutics: A Market Analysis

Image
  In the realm of oncology, thyroid cancer remains a significant area of focus due to its increasing incidence and evolving treatment landscape. According to DelveInsight’s latest report, the thyroid cancer market is poised for substantial growth, driven by advancements in diagnostic techniques, therapeutic innovations, and a growing awareness among healthcare professionals and patients alike. Thyroid Cancer Market Overview and Growth Drivers Thyroid cancer, which affects the thyroid gland, has seen rising prevalence globally. Factors such as increased screening programs, better detection methods, and genetic predispositions contribute to this trend. DelveInsight's analysis highlights a robust pipeline of novel therapies targeting various types and stages of thyroid cancer, promising improved outcomes and survival rates for patients. Key Players and Therapeutic Landscape Leading pharmaceutical companies are actively involved in the development of targeted therapies and immunother...
Read more

Current Scenario and Future Prospects of Wilms Tumor Therapeutics

Image
  Wilms tumor, a rare pediatric kidney cancer, presents unique challenges and opportunities within the healthcare landscape. DelveInsight’s comprehensive analysis sheds light on critical aspects shaping the Wilms tumor market, offering deep insights into its current dynamics and future potential. Wilms Tumor Drugs Market Overview and Size The Wilms tumor market, though niche, is significant due to its impact on pediatric oncology. DelveInsight’s latest report underscores its market size and growth trajectory, driven by advancements in early diagnosis and treatment modalities. With increasing awareness and healthcare infrastructure improvements, the market is poised for steady expansion. Epidemiology and Patient Demographics Understanding the epidemiology is crucial in addressing the unique needs of Wilms tumor patients. DelveInsight’s data highlights prevalence rates, demographic insights, and geographic variations, aiding stakeholders in strategic decision-making and resource all...
Read more

Who are the leading companies in the Inter-alpha-inhibitor Proteins Market Landscape?

Image
  What is the  Inter-alpha-inhibitor Proteins Market ? DelveInsight's "Inter-alpha-inhibitor Proteins Market Insights, Epidemiology, and Inter-alpha-inhibitor Proteins Market Forecast-2032" report delivers an in-depth understanding of the Inter-alpha-inhibitor Proteins, historical and forecasted epidemiology as well as the Inter-alpha-inhibitor Proteins market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. What is the Inter-alpha-inhibitor Proteins Market Report? The Inter-alpha-inhibitor Proteins market report provides current treatment practices, Inter-alpha-inhibitor Proteins emerging drugs, Inter-alpha-inhibitor Proteins market share of the individual therapies, current and forecasted Inter-alpha-inhibitor Proteins market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Inter-alpha-inhibitor Proteins treatment practice/algorithm, Inter-alpha-inhibitor Proteins market drivers, Inter...
Read more